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Preliminary observations (1) on serums from cases of acute hepatitis follow- 
ing yellow fever vaccination have indicated  the existence of an  "antigen"  in 
acute-phase serums which precipitates with an "antibody" in serums obtained 
during convalescence?  This phenomenon resembles in its general aspects the 
serum antigen-antibody reaction which was observed by Hughes (2)  in yellow 
fever.  Since  the  latter  author  attributed  the  reaction  to  a  product  of liver 
damage rather than to a specific antigenic component of the causative virus, it 
seemed likely that a similar liver damage reaction might occur in acute infective 
hepatitis.  In view of this possibility, complement fixation tests were done with 
various samples of fiver tissue.  The investigation  showed that  serums from 
certain cases of acute hepatitis fixed complement with saline extracts of liver 
from fatal cases of this disease, but that positive reactions of equal intensity 
and frequency were obtained when the same serums were tested with normal 
human liver tissue. 
Another aspect of serological reactions in acute hepatitis was suggested by 
the  observations  that  serums  from these  cases  often  showed  slightly  higher 
titers of agglutinins for sheep ceils than did normal serums.  2  The possibility 
of a  heterophile reaction analogous to that found in infectious mononucleosis 
(3)  was  considered.  Heterogenetic  antibodies  have  also  been  described  in 
serum sickness  (8),  and  the  occurrence  of urticaria  and  arthralgia  in  certain 
cases  of  acute  hepatitis  suggested  the  possible  association  of  immunological 
* The studies and observations reported in this paper were initiated  by a  study 
group of the Commission on Tropical Diseases under the Board for the Investigation 
and Control of Influenza and Other Epidemic Diseases in the Army, Preventive Medi- 
cine Service, Office of the Surgeon  General,  United States Army, and continued with 
the  support  and  under  the  auspices  of The  Rockefeller  Foundation  Health  Com- 
mission working in cooperation with the California State Department of Health. 
Released for publication by the Bureau of Public Relations of the War Department 
on January 19, 1944. 
1 The first of these experiments was performed by Major ~ames H. Gear and Dr. 
Max Theiler at the Laboratories of the International Health Division of The Rocke- 
feller Foundation in New York. 
2 Colonel  Raymond O. Dart (Medical Corps) and Lieutenant Colonel  Gerson R. 
Biskind (Medical Corps), Letterman General Hospital, personal communication. 
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reactions like those of serum sickness.  Recently the existence of heterogenetic 
antigen-antibody phenomena in  primary atypical pneumonia  has  been  sug- 
gested by the discovery in this disease of cold agglutinins (4, 5) and associated, 
but ill defined, heterogenetic antibodies reactive with  certain animal  tissues 
(6, 7). 
Further studies indicated that the complement fixation with human liver and 
the  agglutination  of sheep cells were frequently associated in cases of acute 
hepatitis, and absorption experiments suggested that a single antigen-antibody 
system was concerned in these two serological reactions. 
The relation of the soluble antigen found in the acute-phase serums from some 
cases of hepatitis,  as previously described (1), to the heterogenetic reactions 
with  fiver and sheep cells is not  clear at  the present  time.  At first it was 
thought that this serum antigen was a  product of liver damage which might 
have stimulated the production of antibodies to liver tissue and sheep cel]s as 
well as that of the precipitin which was found in the serums of some persons 
convalescent from hepatitis.  Preliminary experiments to test for such a rela- 
tionship  were  unsuccessful and  indicated,  on  the  contrary,  that  the  serum 
antigen-antibody system was separate from the other reactions.  The serum 
antibody appeared later in the course of convalescence from hepatitis than did 
the antibodies  to human liver and sheep cells.  This antibody could not be 
absorbed either with human liver or with  sheep cells by the methods to be 
described.  It was also found that some serum specimens reacted not only with 
serum antigen or antibody from cases of jaundice, but also with serums from 
normal persons?  Further investigation is being made  of  the  nature  of the 
immunological reactions between serums from cases of jaundice, but space does 
not permit the presentation of details at present. 
This paper will be limited to a report of preliminary observations on a hetero- 
genetic antibody which occurs in cases of acute infective hepatitis and is charac- 
terized by fixation of complement with human liver and agglutination of sheep 
erythrocytes.  Differences from the Forssman antibody, from the Wassermann 
antibody, and from heterogenetic antibodies occurring in other diseases have 
been noted. 
Materials and Methods 
Serums.--Specimens of serum were collected from 154 cases of jaundice attributed 
to yellow fever vaccination in the United States Army and from 68 cases of so called 
"catarrhal" jaundice which occurred either in small family or institutional outbreaks 
among civilians, or as sporadic disease.  4  Blood was collected in some cases as soon 
s The possibility of immunological reactions between human serums from different 
individuals  has been indicated in various published reports (9-11). 
4  We are indebted to Miss M. Dorthy Beck of the Bureau of Epidemiology, Califor- 
nia State Department of Public Health, for obtaining  some of the specimens from 
civilian cases. ~O~rRO~  D.  EATON, Wn~LrA~  D.  mYRPHY,  V.  LEE  HANrORD  541 
as possible after the diagnosis was established and again several weeks later, or during 
convalescence.  A  number of single specimens taken from 5 to 150 days after onset 
of jaundice were also received.  As controls, serum specimens from cases of infectious 
mononucleosis, from cases of primary atypical pneumonia, and from normal persons 
without history of jaundice, were also available. 
Samples of serum were heated at 56°C. for a half-hour immediately before use.  A 
considerable number of the serums from cases of jaundice became anticomplementary 
after storage for periods of a week to several months.  Later it was found that some 
of the antieomplementary serums could be made usable by heating to 60°C. for 15 
minutes. 
Antigen for Complement Fixation.--Preliminary experiments showed that jaundice 
serums gave no stronger fixation with suspension of liver from fatal cases of hepatitis 
than with suspensions of normal human liver.  For this reason suspensions of liver 
tissue from a fatal case of coronary occlusion without history of jaundice were used in 
most of the experiments to be described.  The specimen of tissue contained a  few 
intestinal bacteria, but these were not present in large enough numbers to account 
for the observed reactions.  Additional tests were done with two other samples of 
normal human liver with almost identical results. 
The tissue was ground with alundum and saline to make a  i0 per cent suspension, 
which was then centrifuged at approximately 1,500 mp.x~, for 10 minutes.  The result- 
ing suspension was moderately turbid.  The suspensions of antigen were stored at 
-70°C.  until used.  The  antigens were always anticomplementary at  10 per cent 
concentration and sometimes slightly so at 5 per cent.  In most tests the equivalent 
of a concentration of 2 per cent by weight of wet tissue was used.  Alcoholic extracts 
of human liver were also used in tests to be described in a subsequent section.  The 
antibody which fixed complement with suspensions or extracts of human liver will be 
referred to in the remainder of this paper as liver antibody. 
Method of Performing the Complement Fixation Test.--A hemolytic system consisting 
of equal parts of 5 per cent sheep red ceils and diluted anti-sheep rabbit serum was 
used.  The complement fixation test was set up as follows:-- 
0.2 cc. serum usually at a single dilution of 1:4. 
0.2 cc. complement diluted to contain 2 units. 
0.2 cc. antigen diluted as described above. 
Controls: 
1.  Serum diluted 1:4 with complement and saline in place of antigen. 
2.  Antigen at dilution used in test with complement and saline in place of serum. 
3.  Normal serums were usually run in parallel with jaundice serums. 
All tests were incubated at 37°C. in a water bath for 1"hour.  The hemolytic sys- 
tem, consisting of 0.5 cc. of a mixture of equal parts of 5 per cent sheep red cells and 
amboceptor diluted so as to contain 2 units per 0.25 cc., was then added to each tube. 
After an additional 30 minutes' incubation the tests were read.  Results were recorded 
as 0,  q-,  A-+,  q-A-q-, or -4-q-q-+, depending on the estimated degree of hemolysis 
of the sheep cells, 0 indicating complete hemolysis and  -4-+ +  +  no hemolysis. 
Agglutination Tests.--These  were performed with the erythrocytes of the sheep, 
rabbit, horse, and rhesus monkey, and with bovine red cells.  The cells were washed 
three times with saline, packed, and resuspended in saline to a concentration of 2 per 
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were usually less than 4 days old.  To serum dilutions of l:10,  1:20, 1:40, etc., in 
Wassermann tubes an equal volume of the erythrocyte suspension was added.  The 
mixture of cells and serum was held at 20°C. for 10 minutes, and the tubes were then 
centrifuged at 1,700 l~.p.~s, for 10 minutes in the horizontal head of an International 
centrifuge.  The tests were read by flipping the bottom of the tubes with the index 
finger  to mix  the  sedimented  cells  and  superuatant.  Titers  were recorded  as  the 
original dilution of serum before addition of red cell suspensions. 
Human blood types of the cases of jaundice were determined by using the serums in 
macroscopic plate tests with known type A  and B  erythrocytes.  Doubtful results 
were checked by microscopic examination. 
Absorption Technique.--Absorption experiments  were done on samples  of serum 
from cases of acute hepatitis,  infectious mononucleosis, and bronchopneumonia, or 
from normal persons to determine what materials removed the human liver antibody 
and the sheep cell agglutinins.  For this purpose, suspensions of human liver, washed 
sheep or rabbit erythrocytes, boiled guinea pig kidney, and boiled beef erythrocytes 
were used. 
Suspensions of human liver were prepared  as for complement fixation and  used 
in 10 per cent concentration.  One part of serum and S parts of the liver suspension 
were mixed, incubated at 37°C. for 1 hour, and centrifuged at 2,000 R.P.M. for 10 min- 
utes.  To the  supernatant  an  additional  2½ parts  of liver suspension  was  added; 
the mixture was incubated again at 37°C. for 1 hour and then placed in the ice box 
overnight.  The supernatant, after centrifuging at 3,000 it.p.,s,  for 30 minutes in the 
angle centrifuge and inactivation at 56°C.,  was used for  complement  fixation  and 
agglutination tests.  The final dilution of serum after absorption with liver was 1 : 7.5. 
Absorptions with washed fresh sheep red cells  and rabbit red cells were done by 
adding 2½ volumes of 10 per cent red cell and incubating for 1 hour at 37°C. followed 
by a second absorption with packed red cells overnight in the ice box. 
The suspensions of guinea pig kidney and beef cells  were prepared  in the usual 
manner.  20 per cent suspensions were heated in a boiling water bath for 1 hour.  One 
part of serum and 5 parts of these suspensions were mixed, allowed to stand overnight 
in the ice box, and centrifuged at 2,000 R.I'.M. for 10 minutes. 
Serums,  after  absorption with  these  materials,  were inactivated  at  56°C.  for ~/~ 
hour, and the dilutions were adjusted  to 1:5 for complement fixation and  1:10 for 
the initial dilution in agglutination tests. 
Complement Fixation with Human Liver and Agglutination of Sheep 
Erythrocytes by Serums from Acute Hepatitis, from Other 
Diseases, and from Normal Persons 
Single or paired serum specimens from cases of jaundice, atypical pneumonia, 
infectious  mononucleosis,  and  upper  respiratory  infections,  and  from  other 
persons before or after  inoculation with  chick embryo influenza vaccine were 
tested by complement fixation with the liver antigen and by agglutination of 
sheep erythrocytes.  The purpose of these tests was to determine whether these 
two reactions are associated in cases of jaundice and whether a similar antibody 
is found in diseases other than jaundice. 
In Table I  the results with 4 groups of serums are presented. MONROE  D. EATON, WILLIAM D. M'URI~HY, V. LEE HAN~ORD  543 
In this and subsequent tables the term "postvaccinal hepatitis" is used to designate 
the disease apparently resulting from inoculation with yellow fever vaccine.  "Infec- 
tive hepatitis" designates those cases which occurred in civilians and were not con- 
nected with yellow fever vaccine.  These terms are used without prejudice as to the 
identity of the two diseases or the possible diverse etiology of acute hepatitis.  The 
first 2 groups in Table I included specimens from cases of hepatitis.  The third group 
was composed of specimens from cases of primary atypical pneumonia or pneumonitis 
of which a large number were available.  The last, or "normal," group also included 
TABLE I 
Complement Fixation  R,  actions with  Human  Livor and  Sheep  Cell AggluHnation in  Case~ 
of Jaundice, Primary Atypical Pneumonia, and Normal Control Serums 
Serum specimen from 
Postvaccinal 
hepatitis 
Infective 
hepatitis 
Atypical 
pneumonia 
Normal controls 
Complement fixation  with liver 
R~c~n 
Positive 
Negative 
Anticomplementary 
Total 
Positive 
Negative 
Total 
Positive 
Negative 
Anticomplementary 
Total 
Positive 
Negative 
Anticomplementary 
Total 
Number 
47 
63 
44 
154 
2O 
48 
68 
ll 
3O 
15 
56 
11 
120 
11 
142 
Per cent with sheep cell titers of 
0 to 20  4C to 
32  62 
52  43 
36  48 
42  50 
30 
57 
49  38 
64  36 
83  17 
80  20 
79  21 
82  18 
18 
89  II 
)  160 or 
over 
6 
5 
16 
8 
30 
6 
13 
0 
0 
0 
0 
0 
0 
0 
0 
persons with upper respiratory  infections and those who had received influenza vaccine. 
The data were assembled without selection as to date of onset, but duplicate results 
for  paired  serum  specimens  have  been  eliminated.  Where  different results  were 
obtained with 2 serums of a pair, the positive complement fixation reaction and the 
highest sheep cell agglutination titer were counted.  Further details of the results 
with these paired specimens will be presented in  the next section.  In  8  cases of 
jaundice and 5 cases of atypical pneumonia the serums were slightly anticomplemen- 
tary,  while the reaction with liver antigen was  +  +  +  or  +  +  +  +.  These  were 
counted as positive, with the reservation that the result was somewhat in doubt. 
When the over-aU results for sheep cell agglutination, given under totals for 
each group in Table I, are considered it is evident that titers over 20 occur in a 
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cal pneumonia  (21  per cent),  or in normal serums  (11  per cent).  From the 
data presented  in  the  third  column of the  table it will be seen that positive 
complement fixation reactions varying from -k to -[-++q-  with human liver 
antigen were obtained in about one-third of the cases of hepatitis, one-fourth 
of the  cases of atypical pneumonia,  and  one-eleventh of the normal controls. 
TF.xT-Fm.  1.  Sheep cell agglutination titers in serums with positive and negative 
liver antibodies from 110 eases of postvaccinal hepatitis, 68 cases of infective hepatitis, 
41 cases of atypical pneumonia, and 131 normal persons. 
In those serums from cases of hepatitis with positive liver antibody, sheep cell 
titers over 20 were more frequent (68 to 70 per cent) than in serums from the 
same disease with negative liver complement fixation, in which the proportion 
with titers over 20 was 43 to 48 per cent. 
The same data are presented graphically in Text-fig. 1. 
The length of each column above the solid line in the middle of the graph represents 
the percentage of positive complement fixation reactions with human liver antigen, 
while  that below the line indicates the negative reactions.  Each column is divided 
by cross-hatching according to the percentage of the total group (liver positive plus 
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shows that liver antibody associated with elevated sheep cell agglutination fiters was 
found much more frequently in cases of jaundice than in atypical pneumonia or in 
normal  individuals.  In the serums  negative for liver antibody elevated sheep cell 
titers also occurred with somewhat  greater frequency in the hepatitis group than in 
the control group.  It is likely that more of the jaundice serums would have given 
positive complement fixation with liver antigen if they had been tested at lower dilu- 
tions, and this might have brought about a closer correspondence between the liver 
antibodies and sheep cell agglutinins. 
Serums from 15 cases of infectious mononucleosis with sheep cell agglutina- 
tion titers rangin~ from 40 to 1,280 were also tested by complement fixation 
with  the  human  liver antigen.  One  of these  gave  a  positive reaction.  In 
addition, 6 other serums with low agglutination titers from cases with a doubt- 
ful or tentative clinical diagnosis of infectious mononucleosis were also tested. 
Of these, 3  gave weakly positive complement fixation reactions with human 
liver.  A number of the serums which gave positive reactions with liver were 
found to be Wassermann negative. 
Time Relation of Serological  Reactions to Onset of Icterus 
Paired serum specimens collected from 46 cases of infective hepatitis were 
available.  The first serum of each pair had been collected 1 to 27 days after 
onset of icterus and the second specimen 20 to 150 days after onset.  It was 
not possible to do complete serological studies on all of the paired specimens 
because of an insufficient quantity of serum and, in several cases, one or both 
serums in the pair became anticomplementary after several tests had been run. 
The results with paired specimens from 22 cases are presented in Table II. 
The complement fixation reaction with human liver was not consistent, 7 cases 
showing an increase in these reactions between the first and second specimens, 
while 7 others showed a decrease.  It must be noted, also, that the intensities 
of the reactions with liver and sheep erythrocytes sometimes rose and fell in 
parallel (serums 6 and 7), but sometimes showed opposite tendencies (serums 
17 and 21).  With 11 other pairs of serums no positive reactions for liver anti- 
body and  no  significant  changes  in  the  sheep  cell agglutination  titers  were 
observed.  On the remaining specimens the data were incomplete. 
Control tests were run on paired serum  specimens from 9 cases of broncho- 
pneumonia,  9  cases of infectious mononucleosis, and from 20 persons before 
and after inoculation with influenza vaccine.  In  1 case diagnosed clinically 
as infectious mononucleosis, but having no significant sheep ceU agglutination 
titer, a weak reaction with liver antigen occurred in the second specimen.  In 
1 case of bronchopneumonia a one-plus complement fixation with fiver antigen 
was found in the serum specimens collected on the 4th day, but was absent in 
specimens collected on the 8th and 20th days.  In 1 person receiving influenza 
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serum.  Thus, in a total of 3 out of 38 persons not having hepatitis, weak reac- 
tions with human liver seemed to appear or disappear during the interval of 
time between the collection of the 2 serum specimens. 
TABLE II 
Results of Serological Tests on Paired Serum Specimens from Cases of Hepatitis Following Yellow 
Fever Vaccination and from Cases of Hepatitis Not Associated witk Vaccination 
Seruin 
lq'o. 
1  Postvaceinal 
2  hepatitis 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12  Infective 
13  hepatitis 
14 
15 
16 
17 
18 
19 
20 
21 
22 
Disease 
Time after onset  Liver antibody  Sheep cell  agglutination titer 
First  Second  First  Second  First  Second 
specimen  specimen  specimen  specimen  specimen  specimen 
days  days 
9  43  .4-  0  5  20 
?  ?  0  +  5  5 
9  45  +  + +  20  40 
6  42  +-4-  10  20 
3  34  +  ++  40  10 
14  36  0  +++  10  40 
5  30  0  0  20  80 
1  31  "4-  5  20 
12  32  0  +  80  160 
10  24  ++  0  40  20 
9  21  0  ++  160  160 
7  120  +  0  10  10 
7  120  ++  10  10 
4  120  0  0  40  10 
9  62  0  0  160  40 
12  66  ++  0  40  160 
21  75  ++  0  160  40 
13  65  +++  0  40  40 
16  68  0  0  160  40 
14  55  0  ++  20  5 
3  22  0  O*  10  40 
16  70  +  +  0  80  40 
* Specimen taken on 14th day after onset -4- liver antibody. 
The relation of  the  serological reactions to  the  time of onset of icterus is 
shown in Table III.  These results were obtained with all the specimens, both 
single and  paired,  from  cases  in which  the  date  of  onset  was  known with 
reasonable accuracy.  The  data  for  complement-fixing antibodies to  human 
fiver indicate that  this reaction was  present in a  considerable proportion of 
cases in the earliest phases of the disease, and a  large proportion of the cases 
also  showed  sheep  cell  agglutination titers  of  1:40  or  over  during the  first 
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or 8.3 per cent, had fiver antibodies,  while in cases of hepatitis during the first 
10 days after onset of icterus positive reactions were obtained in 17 out of 49, 
or about 35 per cent.  Similar comparisons for the sheep cell agglutinins give 
11  per cent of normal persons with  titers  of 40 or over and 34 per cent with 
similar titers among those in the acute phase of the disease. 
TABLE III 
Relat¢on of Serological Reactions to Time of Appearance of Icterus 
Serum tested for 
Liver antibody 
Sheep cell 
agglutination* 
Kind of hepatitis 
Postvaccinal 
Infective 
Totals 
Postvaccinal 
Infective 
Totals 
Days after onset 
I to 10  11 to 30  31 to 60  61 to 150 
Posi- 
tive 
13 
4 
17 
16 
9 
25 
Nega- 
tive 
17 
15 
32 
3O 
9 
39 
Posi-  Nega- 
tive  tive 
18 
13 
31 
19 
9 
28 
18 
8 
26 
Posi-  Nega- 
t ive  tire 
9 
4 
13 
13 
20 
33 
21 
9 
30 
Posi-  Nega- 
tive  tive 
6  14 
4  12 
10  26 
12  8 
4  13 
16  21 
29 
13 
42 
22 
15 
37 
* In this table, serums with sheep cell titers of 20 or less are called "negative;" those with 
titers of 40 or more are called "positive."  This division is based on tests with normal serums 
described in Table I. 
Agglutination  with Erythrocytes of Other Species 
Agglutination tests with the erythrocytes of rabbits, rhesus monkeys, horses, 
and cattle were done with serums from cases of acute hepatitis and from normal 
persons,  using  the  same  technique  as  for the  sheep  cell  agglutination.  The 
results are presented in Table IV.  In the agglutination of rabbit erythrocytes 
the titers of serums from 45 cases of jaundice tended to be higher than the titers 
of normal serums.  There was no significant difference between hepatitis  and 
normal serums  in  the  agglutination  titers  with  the  erythrocytes of the  other 
3 species tested. 
Absence of Rdation of the Heterogenetic Antibody  in Hepatitis  to the Principal 
Human Blood Groups 
Determination  of  blood  group  was  done  on  193  cases  of  jaundice.  The 
results,  arranged according to complement fixation reaction with human liver 
and agglutination of sheep erythrocytes, are presented in Table V.  It is doubt- 
ful that much significance can be assigned to the slight variations from normal 
such as the lower proportion of group B individuals among those having positive 
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AB.  These  results do not  include tests on  9  cases of jaundice in American 
Indians, all of whom were group 0. 
TABLE IV 
Agglutination of grythrocytes of Various Species with Jaundice and Normal Serums 
Erythrocytesused 
in tests 
Rabbit 
~]~$U$ 
Horse 
Cattle 
Serum from 
Hepatitis 
Normal 
Hepatitis 
Normal 
Hepatitis 
Normal 
Hepatitis 
Normal 
No.  tested  100 or  ~  --  800 or 
less  200  400  over 
45*  [  9  [  li  [  44  [  36 
3o  13o  143  L27  I  o 
Per cent with  titers  of 
10 or less  20  40  80 or 
over 
20  55  25  20  0 
19  26  37  26  11 
16  12  38  25  25 
17  47  47  6  0 
17  41  53  6  0 
* By complement fixation  with human liver--ll positive, 12 negative, 22  anticomple- 
mentary. 
TABLE V 
Human Blood Groups of Cases of Hepatitis 
Liver positive  ................. 
Liver negative ................ 
Sheep cell titer over 20 ......... 
Sheep cell titer less than 20 ..... 
Normal distribution*  ........... 
No.  tested 
56 
93 
105 
88 
Per cent of blood  group 
°__k__  ^_2__ 
48[  41]  2  ]  9 
38]  41  j  is  ]  6 
47  42  6  ]  5 
35  ]  14  l  n 
45  41  10  4 
* In the white population of the United States as reported by W. C. Boyd, Fundamentals 
of immunology, New York, Interscience Publishers, Inc., 1943, 151. 
Absorption Experiments 
The  two principal purposes of the absorption experiments were  to demon- 
strate the relation between the liver antibody and sheep cell agglutinin in cases 
of hepatitis and to differentiate these reacting substances from other hetero- 
genetic antigen-antibody systems.  The absorptions were done with unheated 
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rabbit and sheep erythrocytes,  as described in the  section on Materials and 
methods. 
The results of absorption experiments with serums from 20 cases of infective 
hepatitis, which were selected because of elevated sheep cell agglutinins, and 
TABLE VI 
A bsorption of A gglutinins for Sheep Erythrocytes in Serums from Cases of Hepatitis 
SerUlll 
No. 
115 
120 
121 
124 
126 
139 
153 
103 
50 
16 
17 
192 
193 
227 
228 
256 
257 
258 
268 
259 
287 
260 
268 
Disease 
Postvaccinal 
hepatitis 
Infective 
hepatitis 
Hepatic 
cirrhosis 
Sheep cell  agglutination  titer after absorption  with 
Liver antibody  titer  Human Guinea Rabbit Boiled 
Nil  liver  k'P'tgylane eryth-  beef  Sheep  rocytes  eryth-  cells  rocytes 
+-4-++  1:4  40  0  10  0  0 
0  1:4  80  10  0 
0  1:4  40  0  10 
0  1:4  160  0  0 
0  1:4  80  0  0 
@@  1:4  40  20  0 
80  10  10 
+@-t-  1:4  160  40  0 
40  0 
+@  1:4  40  20  20  10  0 
+@  1:4  40  10  0  0 
40  10  0  0 
@@-b  1:4  160  0  10  0 
@  1:4  80  40  10 
+@  1:4  80  20  10  0 
4-  1:4  10  10  0 
0  1:4  160  40  10 
4-  1:4  160  10  10 
4-  1:4  40  10  0 
@+@  1:4  20  0  0  0 
.4-.4-4  -  1:4  40  10  0  ,  0 
0  1:4  40  20 
@@@-4-  1:4  40  10 
0, titer less than 10 except in cases noted. 
2  cases of chronic hepatic cirrhosis with jaundice are presented in Table VI. 
In 18 cases of jaundice and I  case of chronic hepatic cirrhosis, the titer of sheep 
cell agglutinins was  significantly reduced  (over twofold)  by absorption with 
human liver.  The agglutinins were also removed with equal or greater com- 
pleteness by absorption with guinea pig kidney and rabbit erythrocytes.  Five 
serums (Nos.  16, 50, 192, 193,  and 256) from cases of acute infective hepatitis 
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cell  agglutinins  were  not  absorbed  by  liver.  Of  the  remaining  13  serums 
collected after the 12th day, the absorption was successful in all except 2  (Nos. 
TABLE VII 
A bsorption of A gglutinins for Sheep grythrocytes in Control Serums Not from Hepatitis 
~rllllq 
No, 
818 
795 
796 
262 
272 
039 
105 
058 
020 
742 
031 
500 
469 
637 
607 
608 
609 
432 
922 
993 
042 
686 
697 
216 
242 
243 
247 
Disease 
Serum sick° 
ness 
Mono- 
nucleosis 
Pneu- 
monitis 
Normal 
Contact to 
jaundice 
Liver antibody 
titer 
0  1:4 
0  1:4 
+  1:4 
0 
++++  1:4 
0  1:4 
+++  1:4 
0  1:4 
0  1:4 
+++  1:4 
0  1:4 
0  1:4 
0  1:4 
+  1:4 
-4-  1:4 
+++ 
++ 
Sheep cell agglutination titer after absorption with 
Boiled  ~_ 
Nil  t  aman  G  alnea  R~ bbit  beef 
~l~e  er  3 thro-  eryth-  e~  iver  k [  y  c rtes  ro- 
cytes 
150  10 
80  0 
80  0 
320  320  0 
320  320  0 
320  10  0 
320  320  10  10 
8O 
80 
80  80  0 
1280  640 
1280 
1280  1  1280  0 
40  0 
40  0 
40  40 
1:5  +  0  0  1:5 
80 
40  0 
20 
1:5  +  0  +  1:5 
40  0 
40  0 
80 
40  10 
160  20 
80  0 
0 
10 
139 and  227).  It is also evident that  the absorption  of sheep cell agglutinins 
by liver occurred irrespective of whether  the complement fixation reaction for 
liver antibody was positive or negative. 
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case of serum sickness,  12 cases of infectious mononucleosis, 4  cases of pneu- 
monitis, and 10 normal persons, 4 of whom were contacts to cases of infective 
hepatitis  in  one of the  outbreaks  among  civilians.  In  these  27  serums  the 
agglutinins for sheep erythrocytes were significantly absorbed by human liver 
in only 1 case, normal serum 432. 
TABLE  VIII 
A bsorption in Serum from Infective Hepatitis of A gglutinins for Sheep Erythrocytes by Various 
Human Tissues 
Sheep cell agglutination titer after absorption with 
Senun No. 
Serum No. 
[  Liver  ] ~a  ""  [  Spleen  Kidney  Lung  •  j  unotce  Jaundice  Nil  heated to  ..  "  [  liver 2  Brain  1060C.  l ", ¢r i  ..... 
4o  ao  I  xo  I  xo  20  10  4o  4o 
4o  I  1°  I  °  I  0  20  I  0  I  40  I  4o 
40  I  10  I  0  I  0  I  10  I  20  J  4o  I  4o 
TABLE  IX 
Absorption of Liver Antibody with Various Materials 
Disease 
Nil 
191 
193 
278 
105 
6O9 
042 
216 
Hepatitis 
Hepatitis 
Hepatitis 
Mononucleosis 
Pneumonitis 
Normal 
Normal 
Complement fixation with human liver antigen after absorption 
with* 
+  ++++ 
$+++ 
Rabbit  Sheep  eryt]  eryth- 
rocytes  rocytes 
o  o 
o 
o  o 
o 
++  4- 
o  o 
+++ 
120 
121 
139 
Guinea pig 
kidney 
+ 
++ 
+ 
o 
++ 
o 
Beef 
~yth. 
rocyte$ 
* Serum dilutions 1:5 after absorption. 
The mononucleosis antibody differed from that found in jaundice in not being 
absorbed by human liver, guinea pig kidney, or rabbit erythrocytes.  In the 
serums from cases of pneumonitis and from normal individuals positive absorp- 
tions were obtained with guinea pig kidney and rabbit erythrocytes with one 
or  two  exceptions.  Absorptions  with  these  materials  are,  therefore,  of  no 
value in differentiating jaundice serums from normal ones. 
Other human  tissues were tested for their ability to absorb the sheep cell 
agglutinins from jaundice sera.  The results in Table VIII indicate that liver 
heated to 100°C.  for 60 minutes retains the ability to absorb the agglutinins. 
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also  had  this property.  The  agglutinins were  absorbed  less constantly by 
spleen and kidney than by liver.  Absorptions  with lung and brain did not 
reduce the titers appreciably. 
Reciprocal absorptions  of the liver antibody using guinea pig kidney and the 
erythrocytes of sheep,  rabbits,  and cattle were also  done.  This study was 
hindered by shortages of serum and by technical difficulties, principally those 
due to anticomplementary effects.  The results of a few of the more successful 
experiments  are presented in Table IX.  The liver antibody was apparently 
absorbed out with sheep cells, beef ceils, and rabbit cells, but not by guinea pig 
kidney.  This negative result with guinea  pig kidney is difficult to explain in 
view of the fact that this material absorbed  the agglutinins for sheep  cells. 
The results with 4 control serums not from cases of hepatitis were variable, but 
none behaved in exactly the same way as the jaundice sera.  It is noteworthy 
that in 2 of the control serums  the complement-fixing antibodies for human 
liver were not absorbed by sheep cells. 
Nature of the Reacting Antigen 
Heat Stability.--When suspensions of liver were heated to temperatures of 
56°C. or higher for 1 hour, a heavy coagulum formed.  No fixation of comple- 
ment occurred  when the supernatant was mixed with serum containing liver 
antibody.  However,  the  resuspended  sediment from suspensions  heated to 
90°C. for 1 hour fixed complement with some jaundice serums and, as reported 
in the previous section, absorbed the agglutinins for sheep erythrocytes.  These 
rather incomplete data indicate that the antigen in liver which is concerned in 
complement fixation and inhibition of agglutination is heat stable, but is carried 
down in the particles  of coagulated protein when aqueous suspensions of liver 
are heated. 
Extraction with Alcohol.--The  human liver tissue was thoroughly broken up 
by grinding  in a mortar, then dried at about 100°C. in an oven.  The dried 
material was then pulverized and extracted for several days with a volume of 
absolute ethyl alcohol equal to 10 times the weight of wet liver.  The alcoholic 
extract was evaporated to a small volume, about 1/6 to 1 cc., and a volume of 
physiological saline equal to that of the alcohol used in extraction was added 
rapidly.  Mter  thorough shaking the  suspension  was  filtered  through  lens 
paper or cheese cloth to remove large clumps.  The resulting milky suspension 
was  used  in  complement  fixation,  flocculation,  and  agglutination-inhibition 
tests. 
The results of complement  fixation  tests with about 30  serum  specimens 
suggested that the complement-fixing antigen in the human liver was extract- 
able with alcohol.  Serums  from cases of hepatitis which  fixed complement 
with saline suspensions of whole liver also fixed complement with the alcoholic 
extracts of liver.  Normal se~rums and jaundice serums negative for liver anti- 
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Preliminary  experiments  also  indicated  that  the  alcoholic  extracts  were 
flocculated by serums from cases of jaundice, but these results were not readily 
reproducible.  Three syphilitic serums strongly positive by the Kline, Kahn, 
and Kolmer tests gave no flocculation of an alcoholic extract of human liver 
which did flocculate with jaundice serums. 
Inhibition of sheep erythrocyte agglutination was  obtained by mixing the 
alcoholic extract and serum before addition of the ceils.  The antigen diluted 
1:2 and  1:8 was added to appropriate serum dilutions and the mixture incu- 
bated/or 1 hour.  2 per cent sheep cells were then added and the experiment 
completed in the same way as for the sample agglutination test.  The results 
with serums from 4 cases of hepatitis and 2 cases of infectious mononucleosis 
are presented in Table X.  Although the inhibition of agglutination by alco- 
holic extracts was not as definite as the absorption of the agghtinin by whole 
TABLE X 
Inhibition  of Sheep Cell Agglutination by Alcoholic Extracts of Human Liver 
~rumNo. 
140 
151 
154 
159 
2500 
262 
Disease 
Hepatitis 
Hepatitis 
Hepatitis 
Hepatitis 
Mononucleosis 
Mononucleosis 
With aline 
160 
80 
80 
150 
640 
150 
Agglutination titeu 
With antigen  With antigen 
1:8  1:2 
80  4O 
4O  20 
10  10 
4O  40 
64O  64O 
160  160 
liver,  the results suggest that at least part of the absorbing antigen was ex- 
tracted by alcohol. 
Cephalin-Cholesterol  Flocculation.--The  possibility was  considered that  the 
reactions observed with the alcoholic extracts of fiver might be related to the 
cephalin-cholesterol flocculation phenomenon which has been proposed as a test 
for liver damage  (12,  13).  Various jaundice and normal serums were tested 
with  a  cephalin-cholesterol preparation  purchased  from the  Wilson Labora- 
tories, Chicago, Illinois.  Although flocculation was obtained at various dilu- 
tions from 1 : 10 to 1 : 1,000 with most of the serums tested including the normal 
controls,  no  parallelism  between  the  cephalin-cholesterol reaction  and  the 
presence of serum antigen, serum antibody, liver antibody, or sheep ceU agglu- 
tirdns could be detected. 
DISCUSSION 
The reagin found in cases of hepatitis as described in this paper seems to fit 
the definition of a heterogenetic antibody because it gives immunological reac- 
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of species.  It cannot be claimed on the basis of the available data that the 
presence of this antibody is indicative of one particular form of hepatitis.  It 
is possible that a similar antibody may be found in other diseases where damage 
to the liver parenchyma is a prominent feature.  Although an antibody fixing 
complement  with human  liver  was  found occasionally in  primary  atypical 
pneumonia and in other diseases, elevated titers of sheep cell agglutinins did 
not accompany this reaction as commonly as in hepatitis and the agglutinins 
were not absorbed by human liver tissue.  The occasional complement fixation 
reactions between normal human liver and normal serums may have been due 
to natural antibodies resembling those found in the rabbit by Kidd and Friede- 
wald (24).  Our results are in disagreement with those of Fox et al.  (26) and 
Oliphant, Gilliam, and Larson (27), who reported no fixation of complement by 
liver tissue from cases of hepatitis with serum from this disease.  This dis- 
crepancy may be due to differences in the complement fixation technique or the 
preparation of antigen. 
The heterogenetic antibody in acute hepatitis can be distinguished from other 
hetero-antibodies in human serum primarily by its absorbability by human 
liver tissue.  Forssman antigen is not present in rabbit or bovine erythrocytes, 
but these seem capable of absorbing the liver antibody and the agglutinins for 
sheep erythrocytes in the serums from hepatitis.  The mononucleosis antibody 
differs definitely from that found in jaundice by its non-absorbability with 
human liver, guinea pig kidney, and rabbit erythrocytes, and by its insolubility 
in alcohol.  The heterogenetic antigen common to human blood group A cells 
and sheep erythrocytes (23)  apparently did not play a  part in the reactions 
because the distribution of the principal human blood groups among serums 
showing significant reactions with liver and sheep cells was essentially normal. 
The fixation of complement with human liver could not be definitely attributed 
to the Wassermann reagin because this reaction occurred with serums that were 
shown to be Wassermann negative and because Wassermann positive serums 
failed to flocculate alcoholic extracts of human liver when tested by a method 
that gave positive floccu]ation with jaundice serums.  The differentiation of 
the hepatitis antibody from the serum sickness antibody (8) is less clear.  Only 
one serum from a known case of serum sickness was available, but the sheep 
cell agglutinins in this serum were not absorbed by human liver.  Because of 
many resemblances in other respects a relationship between the heterogenetic 
antibodies found in jaundice and serum sickness cannot be excluded. 
The antigen in human liver which fixes complement and inhibits the agglu- 
tination of sheep erythrocytes is apparently heat stable and alcohol soluble. 
This indicates that it is probably either a lipoid or a carbohydrate.  Apparently 
a  closely related or identical antigen is present in the erythrocytes of sheep, 
rabbits, and other species.  It is not unlikely that this antigen will be found in 
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were not done in the present study because of the complications that might 
be expected from various unrelated antigen-antibody reactions. 
In  certain  diseases,  heterogenetic  antibody is  produced in response  to an 
antigen which is actually a component of the infecting organism as, for example, 
the appearance of Forssman antibodies in pneumococcal pneumonia  (14) and 
of agglutinins for Proteus vulgaris  in typhus (15).  In other diseases,  hetero- 
genetic antibodies presumably may be stimulated by some antigenic product 
of tissue damage.  To this category probably belong the Wassermann reagin 
in syphilis,  the yellow fever precipitin described by Hughes (2), and possibly 
also  the  heterogenetic  antibody  of infectious mononucleosis  (3).  It  is  not 
possible to determine with certainty in which class to place the heterogenetic 
antibody  found  in  hepatitis,  but  some  evidence  favors  the  tissue  damage 
hypothesis. 
In 1843 Robert J. Graves  5 noted the association of urticaria and arthralgia 
with attacks of acute hepatitis.  During the present studies these manifesta- 
tions of hypersensitiveness have been seen in a  small proportion of cases of 
acute infective hepatitis.  They have also been found in about 10 to 20 per 
cent of cases of hepatitis following yellow fever vaccination (1) and in jaundice 
following  the use of convalescent serum (25).  These symptoms usually pre- 
ceded by several days the appearance of icterus.  The presence of these signs 
of hypersensitiveness and the production of a heterogenetic antibody to a con- 
stituent of liver suggest the possibility that in vivo antigen-antibody reactions 
may occur in some cases of acute hepatitis.  It is conceivable that an antigenic 
complex liberated from the liver tissue in the acute phase of hepatitis, preceding 
the appearance of icterus, gives rise to an antibody which in turn reacts with 
more antigen  in vivo.  This  consideration would by no means  disprove the 
infectious nature of hepatitis because the observed phenomena may be  only 
secondary reactions to parenchymal liver damage produced by a virus or other 
self-propagating agent. 
An additional interesting speculation is the possibility that the liver antibody 
once produced combines with additional antigen in situ in the liver cells and 
causes further  liver damage after  the acute infectious process has subsided. 
This might be the explanation for some of the fatal cases in which the disease 
was greatly prolonged, with findings  at autopsy resembling those of subacute 
yellow  atrophy of the liver (16).  Analogous examples of homologous andautog- 
enous antibody production can be cited in  the work of several investigators. 
Schwentker and Comploier (28) produced antibodies to kidney in rabbits by 
simultaneous injection of bacterial toxins and homologous kidney tissue.  These 
authors  also reported finding  antibodies  to  rabbit  kidney in  92  per cent  of 
scarlet fever patients and 10 per cent of normal individuals, and in scarlet fever 
5  A system of clinical medicine, Dublin, Fannen and Co., 1843, 564. 556  HETEROGENETIC  ANTIBODIES  IN  ACUTE  HEPATITIS 
the antibodies were presumed to be associated  with kidney damage.  Previously 
Schwentker and Rivers (19) had produced antibodies to brain in rabbits with 
suspensions  of homologous brain  autolyzed  or  infected  with  vaccine  virus. 
Other examples of the production of homologous organ-specific antibodies may 
be found in work with the crystalline lens (17, 18) and with skin (21). 
Other investigators have produced tissue damage with anti-organ heterolo- 
gous serums or antigens.  For example, Smadel (22) has described the produc- 
tion of kidney damage in rats with antiserum to rat kidney produced in rabbits. 
A review of the earlier literature will be found in Smadel's article.  Rivers and 
Schwentker  (20)  produced  pathological  changes  accompanied  by  myelin 
destruction in monkeys by repeated injections of aqueous emulsions and alcohol- 
ether extracts of normal rabbit brains.  Although these experiments indicated 
the participation of a lipoid,  Smadel (22) was unable to absorb the "nephro- 
toxin" from anti-kidney sera with alcohol-ether extracts of kidney. 
The serological procedures described in this paper are not particularly satis- 
factory  as  a  diagnostic  test  for  hepatitis.  Further  investigations  will  be 
undertaken  to  devise a  more delicate  and  specific method  of detecting  the 
heterogenetic antibodies of jaundice with red cell agglutination and inhibition 
of this reaction by purified  alcohol-soluble  antigen from liver. 
SUMMARY 
A heterogenetic antibody showing fixation of complement with human liver 
and agglutination  of sheep erythrocytes was found in certain  cases  of acute 
infective hepatitis. 
The antigen  concerned in  these reactions was apparently heat  stable and 
alcohol soluble. 
Differences  from other  heterogenetic  antigen-antibody  systems have been 
noted. 
The  possible relation  of  the  heterogenetic  antibody  to  liver  damage was 
considered. 
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